Evidence map›Paper›PMID 37477391›Full record

ArticleMuscle & nerve2023

Combining electromyography and Raman spectroscopy: optical EMG.

James J P Alix, Maria Plesia, Pamela J Shaw, Richard J Mead, John C C Day

Abstract read
In one paragraph

Article in Muscle & nerve, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

James J P AlixSheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield, UK.ORCID 0000-0001-8391-9749
Maria PlesiaSheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield, UK.
Pamela J ShawSheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield, UK.ORCID 0000-0002-8925-2567
Richard J MeadSheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield, UK.ORCID 0000-0002-3207-0068
John C C DayInterface Analysis Centre, School of Physics, University of Bristol, Bristol, UK.ORCID 0000-0002-1719-5065

Funding

Department of Health IS-BRC-1215-20017Department of Health NF-SI-0617-10077Medical Research Council MC_PC_15034
6 · The paper itself

Abstract

INTRODUCTION/

aimsElectromyography (EMG) remains a key component of the diagnostic work-up for suspected neuromuscular disease, but it does not provide insight into the molecular composition of muscle which can provide diagnostic information. Raman spectroscopy is an emerging neuromuscular biomarker capable of generating highly specific, molecular fingerprints of tissue. Here, we present "optical EMG," a combination of EMG and Raman spectroscopy, achieved using a single needle.

methodsAn optical EMG needle was created to collect electrophysiological and Raman spectroscopic data during a single insertion. We tested functionality with in vivo recordings in the SOD1

resultsA significant difference in CMAP amplitude was observed between SOD1 DISCUSSION: Optical EMG can provide standard electrophysiological data and molecular Raman data during a single needle insertion and represents a potential biomarker for neuromuscular disease.

Indexed as

Amyotrophic Lateral SclerosisSpectrum Analysis, RamanAnimalsDisease Models, AnimalElectromyographyMiceMice, TransgenicMuscle, SkeletalSuperoxide DismutaseSuperoxide Dismutase-1Superoxide DismutaseSuperoxide Dismutase-1ALSbiomarkerEMGmuscleoptical EMGRaman spectroscopy

Identifiers

PMID37477391
PMCPMC10952815

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.